Influence of zeranol and breed on growth, composition of gain, and plasma hormone concentrations.
Seven Angus and six Brangus steers averaging 225 and 245 kg, respectively, were assigned randomly to zeranol (36 mg) implant (I) and no implant (NI) treatments. Steers had ad libitum access to a corn silage diet plus .68 kg of a soybean meal-based supplement fed daily. Steers were bled via jugular catheters on d 0, 28, 56, and 84 at 15-min intervals for 4 h before and 4 h after feeding. Concentrations of growth hormone (GH), insulin (INS), triiodothyronine (T3), thyroxine (T4), and glucose were determined. Whole-body protein and fat contents were monitored. A breed x I interaction (for d 56 to 84 and d 0 to 84) was observed for ADG (P less than .05 and P less than .07, respectively), feed conversion (P less than .05 and P less than .07, respectively), and protein deposition (for d 0 to 29 and d 0 to 84; P less than .07 and P less than .05, respectively). These interactions were attributed to a greater response to I by Angus than by Brangus steers. A feeding x period interaction (P less than .10) was observed for mean GH concentration, and INS, T4, and T3 concentrations were higher (P less than .05) during the 4-h postfeeding period than during the 4-h prefeeding period. The implant increased (P less than .08) mean GH concentration but did not alter the frequency, duration, or amplitude of plasma GH peaks. Steers that were implanted had lower (P less than .05) plasma T3. Brangus steers had lower (P less than .05) plasma glucose, T3, and T4 concentrations than Angus steers. Results indicate that growth factors beyond those measured are responsible for the anabolic response to zeranol.
Williams
J E
JE
University of Missouri, Columbia 65211.
Ireland
S J
SJ
Mollett
T A
TA
Hancock
D L
DL
Beaver
E E
EE
Hannah
S
S
D000273:Adipose Tissue / Q000254:growth & development; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001823:Body Composition / Q000187:drug effects; D001947:Breeding; D002417:Cattle / Q000097:blood / Q000254:growth & development* / Q000378:metabolism; D004343:Drug Implants; D004734:Energy Metabolism / Q000187:drug effects; D006728:Hormones / Q000097:blood*; D008297:Male; D011506:Proteins / Q000378:metabolism; D015430:Weight Gain / Q000187:drug effects*; D015029:Zeranol / Q000008:administration & dosage / Q000494:pharmacology*
D001786:Blood Glucose; D004343:Drug Implants; D006728:Hormones; D011506:Proteins; D015029:Zeranol